288 related articles for article (PubMed ID: 8604142)
41. Thermodynamic and structural analysis of phosphotyrosine polypeptide binding to Grb2-SH2.
McNemar C; Snow ME; Windsor WT; Prongay A; Mui P; Zhang R; Durkin J; Le HV; Weber PC
Biochemistry; 1997 Aug; 36(33):10006-14. PubMed ID: 9254595
[TBL] [Abstract][Full Text] [Related]
42. Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation.
Yamaguchi H; Hendrickson WA
Nature; 1996 Dec; 384(6608):484-9. PubMed ID: 8945479
[TBL] [Abstract][Full Text] [Related]
43. CH/pi hydrogen bonds determine the selectivity of the Src homology 2 domain to tyrosine phosphotyrosyl peptides: an ab initio fragment molecular orbital study.
Ozawa T; Okazaki K
J Comput Chem; 2008 Dec; 29(16):2656-66. PubMed ID: 18484636
[TBL] [Abstract][Full Text] [Related]
44. Lad, an adapter protein interacting with the SH2 domain of p56lck, is required for T cell activation.
Choi YB; Kim CK; Yun Y
J Immunol; 1999 Nov; 163(10):5242-9. PubMed ID: 10553045
[TBL] [Abstract][Full Text] [Related]
45. Ligands for the tyrosine kinase p56lck SH2 domain: discovery of potent dipeptide derivatives with monocharged, nonhydrolyzable phosphate replacements.
Beaulieu PL; Cameron DR; Ferland JM; Gauthier J; Ghiro E; Gillard J; Gorys V; Poirier M; Rancourt J; Wernic D; Llinas-Brunet M; Betageri R; Cardozo M; Hickey ER; Ingraham R; Jakes S; Kabcenell A; Kirrane T; Lukas S; Patel U; Proudfoot J; Sharma R; Tong L; Moss N
J Med Chem; 1999 May; 42(10):1757-66. PubMed ID: 10346928
[TBL] [Abstract][Full Text] [Related]
46. Design and biological evaluation of linear and cyclic phosphopeptide ligands of the N-terminal SH2 domain of protein tyrosine phosphatase SHP-1.
Imhof D; Wieligmann K; Hampel K; Nothmann D; Zoda MS; Schmidt-Arras D; Zacharias M; Böhmer FD; Reissmann S
J Med Chem; 2005 Mar; 48(5):1528-39. PubMed ID: 15743195
[TBL] [Abstract][Full Text] [Related]
47. Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds.
Dalgarno D; Stehle T; Narula S; Schelling P; van Schravendijk MR; Adams S; Andrade L; Keats J; Ram M; Jin L; Grossman T; MacNeil I; Metcalf C; Shakespeare W; Wang Y; Keenan T; Sundaramoorthi R; Bohacek R; Weigele M; Sawyer T
Chem Biol Drug Des; 2006 Jan; 67(1):46-57. PubMed ID: 16492148
[TBL] [Abstract][Full Text] [Related]
48. Crystal structure analysis and solution studies of human Lck-SH3; zinc-induced homodimerization competes with the binding of proline-rich motifs.
Romir J; Lilie H; Egerer-Sieber C; Bauer F; Sticht H; Muller YA
J Mol Biol; 2007 Feb; 365(5):1417-28. PubMed ID: 17118402
[TBL] [Abstract][Full Text] [Related]
49. Inhibitors to the Src SH2 domain: a lesson in structure--thermodynamic correlation in drug design.
Henriques DA; Ladbury JE
Arch Biochem Biophys; 2001 Jun; 390(2):158-68. PubMed ID: 11396918
[TBL] [Abstract][Full Text] [Related]
50. Calorimetric examination of high-affinity Src SH2 domain-tyrosyl phosphopeptide binding: dissection of the phosphopeptide sequence specificity and coupling energetics.
Bradshaw JM; Waksman G
Biochemistry; 1999 Apr; 38(16):5147-54. PubMed ID: 10213620
[TBL] [Abstract][Full Text] [Related]
51. Src homology-2 domains: structure, mechanisms, and drug discovery.
Sawyer TK
Biopolymers; 1998; 47(3):243-61. PubMed ID: 9817027
[TBL] [Abstract][Full Text] [Related]
52. Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides.
Waksman G; Kominos D; Robertson SC; Pant N; Baltimore D; Birge RB; Cowburn D; Hanafusa H; Mayer BJ; Overduin M; Resh MD; Rios CB; Silverman L; Kuriyan J
Nature; 1992 Aug; 358(6388):646-53. PubMed ID: 1379696
[TBL] [Abstract][Full Text] [Related]
53. Crystal structures of peptide complexes of the amino-terminal SH2 domain of the Syp tyrosine phosphatase.
Lee CH; Kominos D; Jacques S; Margolis B; Schlessinger J; Shoelson SE; Kuriyan J
Structure; 1994 May; 2(5):423-38. PubMed ID: 7521735
[TBL] [Abstract][Full Text] [Related]
54. Role of electrostatic interactions in SH2 domain recognition: salt-dependence of tyrosyl-phosphorylated peptide binding to the tandem SH2 domain of the Syk kinase and the single SH2 domain of the Src kinase.
Grucza RA; Bradshaw JM; Mitaxov V; Waksman G
Biochemistry; 2000 Aug; 39(33):10072-81. PubMed ID: 10955995
[TBL] [Abstract][Full Text] [Related]
55. Conformationally constrained phosphotyrosyl mimetics designed as monomeric Src homology 2 domain inhibitors.
Burke TR; Barchi JJ; George C; Wolf G; Shoelson SE; Yan X
J Med Chem; 1995 Apr; 38(8):1386-96. PubMed ID: 7537333
[TBL] [Abstract][Full Text] [Related]
56. Phosphotyrosine-independent binding of a 62-kDa protein to the src homology 2 (SH2) domain of p56lck and its regulation by phosphorylation of Ser-59 in the lck unique N-terminal region.
Park I; Chung J; Walsh CT; Yun Y; Strominger JL; Shin J
Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12338-42. PubMed ID: 8618896
[TBL] [Abstract][Full Text] [Related]
57. Src homology-2 domains protect phosphotyrosyl residues against enzymatic dephosphorylation.
Brunati AM; Pinna LA; Bergantino E; Ruzzene M; Cirri P; Ramponi G; Donella-Deana A
Biochem Biophys Res Commun; 1998 Feb; 243(3):700-5. PubMed ID: 9500984
[TBL] [Abstract][Full Text] [Related]
58. The SH2 domain from the tyrosine kinase Fyn in complex with a phosphotyrosyl peptide reveals insights into domain stability and binding specificity.
Mulhern TD; Shaw GL; Morton CJ; Day AJ; Campbell ID
Structure; 1997 Oct; 5(10):1313-23. PubMed ID: 9351806
[TBL] [Abstract][Full Text] [Related]
59. Calorimetric and structural studies of 1,2,3-trisubstituted cyclopropanes as conformationally constrained peptide inhibitors of Src SH2 domain binding.
Davidson JP; Lubman O; Rose T; Waksman G; Martin SF
J Am Chem Soc; 2002 Jan; 124(2):205-15. PubMed ID: 11782172
[TBL] [Abstract][Full Text] [Related]
60. Molecular details of Itk activation by prolyl isomerization and phospholigand binding: the NMR structure of the Itk SH2 domain bound to a phosphopeptide.
Pletneva EV; Sundd M; Fulton DB; Andreotti AH
J Mol Biol; 2006 Mar; 357(2):550-61. PubMed ID: 16436281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
